Galapagos | GLPG - Beneficio Bruto En Ventas

Precio De Mercado
24.52
Cambio Diario
-0.12 -0.49%
Mensual
-12.86%
Anual
15.44%
Q2 Expectativa
24.95




Beneficio Bruto En Ventas Cambio Fecha
argenx SE USD 1.14B 118.49M 2025-12
AstraZeneca USD 12.39B 5M 2025-12
Biogen USD 1.65B 34.6M 2025-12
Genmab DKK 977M 13M 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
GRIFOLS EUR 743.8M 49.13M 2025-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Incyte USD 1.39B 118.68M 2025-12
Merck EUR 2.96B 252M 2025-12
Neurocrine Biosciences USD 787.9M 7M 2025-12
Novartis USD 10.25B 570M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
UCB EUR 3.19B 621M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12